Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

UCLA Medical Center Los Angeles, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States

View all 48 locations

View Trial Details

Completed

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

NCT00534430

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
Locations: Not specified

View Trial Details

Completed

ONC-201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant

NCT03932643

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

NCT03434730

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +23 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

NCT07008820

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Local Institution - 0001 Minato-ku, Tokyo, Japan

View Trial Details

Completed

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

NCT05534620

Conditions: Acute Myeloid Leukaemia (AML), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Bone Marrow Diseases, +9 more
Locations: University of Illinois Chicago, Illinois, United States

The Ohio State University Columbus, Ohio, United States

VCU Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

NCT04902833

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +24 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China

NCT07073690

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Zhijian Xiao Tianjin, China

View Trial Details

Completed

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

NCT05564650

Conditions: Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +13 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT03600155

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions